BOSTON, March 23, 2021 /PRNewswire/ -- The market for alternative meat, eggs, dairy, and seafood products is set to reach at least $290 billion by 2035, as consumers drive unparalleled growth in plant-, microorganism-, and animal-cell-based alternatives, according to a new report by Boston Consulting Group (BCG) and Blue Horizon Corporation (BHC).
The report, titled Food for Thought: The Protein Transformation, reveals that the market for alternative proteins will grow from the current 13 million metric tons a year to 97 million metric tons by 2035, when it will make up 11% of the overall protein market in our base case scenario. Faster technological innovation and full regulatory support could speed growth to 22% of the market by 2035. At that rate, Europe and North America would reach "peak meat" by 2025, and the consumption of animal protein there would actually begin to decline.
Benjamin Morach, a BCG managing director and partner, said, "Alternative proteins could soon match animal protein in taste, texture, and price. We expect parity to spur a new wave of growth, catapulting what is a fairly nascent market today into the mainstream, yielding significant environmental benefits, and facilitating even faster growth."
The adoption of alternative proteins will have a measurable positive impact on the environment, supporting a number of the UN's Sustainable Development Goals including responsible consumption and production, and zero hunger. The shift to plant-based meat and eggs alone will save more than 1 gigaton of CO2 equivalent by 2035—the equivalent of Japan becoming carbon-neutral for an entire year. It will also save 39 billion cubic meters of water, enough to supply the city of London for 40 years.
While the environmental and food security benefits are encouraging, the key to consumer acceptance is parity. Alternative proteins must taste and feel as good as the conventional foods they replace and cost either the same or less. According to our research, this will happen in three stages, with dates varying to some degree depending on the source of alternative proteins and the products they aim to replace:
Plant-based alternatives such as burgers, dairy, and egg substitutes made from soy, pea, and other proteins will achieve parity in 2023, if not sooner.
Alternative proteins made from microorganisms like fungi, yeasts, and single-celled algae will reach parity by 2025.
Alternatives grown directly from animal cells will reach parity by 2032.
Investors, too, have much to gain from the protein transformation, which presents a prime environmental, social, and corporate governance (ESG) opportunity. Significant amounts of capital—in the hundreds of billions—will be needed to perfect alternative-protein technologies and scale them up to industrial levels.
"The alternative protein arena is wide open, and progress is happening fast. There is a real opportunity here for investors to make their moves early and become integral players in the future of food. But to successfully navigate the industry, they must hone their technological knowledge and ensure they're one step ahead of potential disruptions," said BHC managing partner and CEO, Björn Witte.
To arrange an interview with one of the authors, please contact Eric Gregoire at +1 617 850 3783 or [email protected].
About Boston Consulting Group Boston Consulting Group partners with leaders in business and society to tackle their most important challenges and capture their greatest opportunities. BCG was the pioneer in business strategy when it was founded in 1963. Today, we work closely with clients to embrace a transformational approach aimed at benefiting all stakeholders—empowering organizations to grow, build sustainable competitive advantage, and drive positive societal impact.
Our diverse, global teams bring deep industry and functional expertise and a range of perspectives that question the status quo and spark change. BCG delivers solutions through leading-edge management consulting, technology and design, and corporate and digital ventures. We work in a uniquely collaborative model across the firm and throughout all levels of the client organization, fueled by the goal of helping our clients thrive and enabling them to make the world a better place.
About Blue Horizon As a pure play global pioneer with privileged access in the Food 4.0 ecosystem, Blue Horizon has shaped the growth of the alternative proteins market. The company aims to transform the global food industry through impact capital and value creation and invests across the lifecycles of companies that are mission aligned to replace animal proteins with healthy and sustainable alternative sources of protein. Blue Horizon was founded by Roger Lienhard in 2016 and is based in Zurich. To date, the company has raised over USD 650 million and invested in more than 50 companies in the alternative protein sector. Its business model offers an attractive opportunity to invest in the evolution of the global food ecosystem while contributing to a healthy and sustainable world. www.bluehorizon.com